SV
Therapeutic Areas
Brimstalt Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Lead Prodrug Candidate | TAE-expressing cancers (initial focus: Renal Cell Carcinoma, Prostate Cancer) | Preclinical |
Leadership Team at Brimstalt Therapeutics
DC
Dev Chatterjee
Team Member (MD, PhD)
RH
Ross Hamilton
Team Member (PhD)
LC
Leniher Castan
Team Member (PhD)